The exact mechanisms of the platelet adhesion still remain to be clarified. Scanning electron microscopic examinations have demonstrated that platelets adhered on a glass surface are aggregated (Hattori et al. 1973 ). Thus the adhesive ness test in common use seems actually measuring two steps reactions; adhesion of platelets on a glass surface and their following aggregation.
Platelets suspended in plasma or in physiologic saline show a high negative surface charge (Born 1968 ). This negative surface charge is supposed to attribute in maintaining platelets non-aggregated. However, it seems likely that a reduc tion of negative surface charge of platelets may decrease their adhesiveness on a surface with positive charge. N-acetylneuraminic acid (NANA) chiefly attributes to keep the surface negative charge of the cell (Madoff et al. 1964 ).
The platelet aggregation following its adhesion on a glass surface is supposed to be induced by the release of ADP from the platelet. It has been well established that a supply of metabolic ATP is required for ADP-induced platelet aggregation (Hirsh and Doery 1971 F ig. 5. NANA content of human non-adhesive platelet (N=18).
Platelet NANA contents and adhesiveness indices were determined on patients with various hemorrhagic disorders. As shown in Fig. 6 Our present studies demonstrate that the ATP content of non-adhesive platelets is lower than that of adhered platelets and the lactic acid production rate of non adhesive platelets is markedly reduced.
From these results it may be suggested that the negative surface charge due to NANA plays a significant role in the mechanism of platelet adhesion on a glass surface and that metabolic energy supply is required in the mechanism of platelet aggregation following adhesion .
Decreased platelet adhesiveness occurs in thromboasthenia and in the majority of patients with von Willebrand's disease (Salzman 1963; Hellem 1968; Bowie et al. 1969 ). The decreased platelet adhesiveness has also been reported to occur in macroglobulinemia, scurvy, chronic myeloid leukemia and uremia (Hellem 1968) . It has been reported that long-term anti-coagulant therapy reduces platelet adhe siveness (Evans and Irvine 1966) .
Our present studies demonstrate that platelet adhesiveness index is reduced in patients with von Willebrand's disease , ITP, SLE, uremia, liver cirrhosis and long-term Warfarin therapy. Platelet NANA content in these patients is marked ly reduced, showing a significant correlation with platelet adhesiveness index .
